We feel your pain....

For those "accountability" junkies like myself, the current controversy at the US Food and Drug Administration (FDA) is just one more ambulance to chase. The difference here is the degree to which the divisions within the agency are being exposed to public view. From the various reports and photos taken at the Senate Finance Committee hearing, you can see the stunned looks on the faces of folks from FDA and the drug industry who sat next to David Graham as he bluntly called the regulatory process at his agency "broken" and spoke of at least five approved drugs which might be as risky as Merck's painkiller, VIOXX, the subject of the hearings. It seems as if all were unprepared for this public airing of the agency's internal divisions.